CNVIntegrate

CNVIntegrate integrates and analyzes copy number variations (CNVs) and copy number alterations (CNAs) across healthy populations and cancer patients to enable comparative genomic analyses.

Key Features:

• Integration of Diverse Data Sources: Consolidates CNV data from nearly 60,000 healthy individuals across five demographic clusters from the Exome Aggregation Consortium (ExAC) with CNA data from COSMIC and the Cancer Cell Line Encyclopedia (CCLE).
• Inclusion of Population-Specific Datasets: Incorporates CNV and CNA data from Taiwanese healthy individuals and Taiwan Breast Cancer datasets to expand population coverage.
• Cross-Population Statistical Comparison: Implements statistical tools to compare copy number frequencies across multiple ethnic groups to identify population-specific genomic variations.
• Structured CNV/CNA Consolidation: Provides a consolidated, structured repository of healthy and cancer-related CNV/CNA datasets to support comparative analyses relevant to genetic variation and therapeutic research.

Scientific Applications:

• Detection of Genomic Imbalances: Enables identification of CNVs/CNAs that contribute to diseases such as cancer.
• Comparative Disease Genomics: Supports comparison of CNVs and CNAs between healthy and diseased populations to identify variants associated with disease onset and progression.
• Evolutionary and Diversity Studies: Facilitates analyses of gene/genome evolution and the role of genetic diversity in health and disease.
• Target Discovery for Precision Medicine: Provides dataset resources and comparative analyses to inform drug target discovery and precision treatment research.

Methodology:

Integrates large-scale CNV and CNA datasets from ExAC, COSMIC, CCLE, Taiwanese healthy cohorts and Taiwan Breast Cancer datasets and applies statistical comparisons of copy number frequencies across ethnic groups.